Studies indicate that they may be beneficial in treating ulcerative colitis (UC) by modulating intestinal immunity and reducing proinflammatory cytokines such as TNF-α and IL-1β while increasing anti-inflammatory factors like IL-10. The gene discussed is IL1B; the disease is ulcerative colitis.